Supply Chain

Here are seven drug and medical device companies that made headlines in the past week.

While the healthcare industry is full of speculation over Amazon's potential entrance into the pharmacy market, one analyst believes the retailer may be more interested in the medical device market, reports CNBC.

Here are seven articles Becker's Hospital Review published in the last week, including a survey highlighting employers' perceptions of pharmacy benefit managers and Pfizer's plans to auction off its consumer health unit.

Amazon has slowly acquired more than 10 wholesale pharmacy licenses from state boards in the past year, fueling rumors over the retailer's potential entrance into the pharmaceutical supply chain, according to the St. Louis Post-Dispatch.

The FDA reportedly hired Nina Devlin, EpiPen maker Mylan's head of global communications, to serve as a senior communications adviser in the agency, according to The Hill.

Many U.S. employers are concerned about their pharmacy benefit manufacturer's level of transparency, contract complexity and rebate process, according to a report conducted by Benfield on behalf of the National Pharmaceutical Council.

Pfizer will launch an auction process in November to sell off its consumer healthcare business, unnamed sources told Reuters.

Pharmaceutical and medical device companies have collectively spent $208 million on lobbying efforts so far in 2017, according to data from the Center for Responsive Politics, a nonprofit, nonpartisan research group based in Washington D.C.

FDA Commissioner Scott Gottlieb, MD, announced Tuesday new steps the agency will take to foster medical device innovations and development.

Express Scripts saw net income increase in the third quarter of fiscal year 2017 despite a 3 percent dip in revenue, according to recent Securities and Exchange Commission filings.